基于多株L. crispatus的阴道共生菌对阴道微生物组的影响:随机的安慰剂对照试验
Jacques Ravel1, Sheri Simmons2, Eleni Greenwood Jaswa3
1Center for Advanced Microbiome Research and Innovation, Institute for Genome Sciences and Department of Microbiology & Immunology, University of Maryland, School of Medicine, Baltimore, MD, USA.
NPJ biofilms and microbiomes
|August 9, 2025
概括
一种阴道共生菌有效地恢复了由L. crispatus (CST I) 主导的健康的阴道微生物组. 这种多菌株益生菌显著增加了有益细菌,并减少了有害微生物,如Gardnerella vaginalis和Candida.
科学领域:
- 微生物学 微生物学
- 妇科 妇科医生 妇科
- 临床试验 临床试验
背景情况:
- 阴道微生物群在生殖健康中起着至关重要的作用.
- 乳酸菌 (L. crispatus) 是维持健康的阴道环境的关键物种,通常与社区国家类型I (CST I) 相联系.
- 阴道微生物不平衡的特征是失生症,与各种妇科问题有关.
研究的目的:
- 评估多菌株阴道共生菌在恢复健康的阴道微生物组中的有效性.
- 评估协生菌对L. crispatus丰富性的影响以及转向CST I. 的转变.
- 为了研究共生菌对减少潜在的致病微生物的作用,如Gardnerella vaginalis和Candida.
主要方法:
- 进行了一项临床试验 (NCT05659745) 以比较多菌株阴道共生药与安慰剂.
- 分析了阴道微生物组的组成,以确定L. crispatus的丰富性和CST I的流行率.
- 该研究测量了L. crispatus水平的变化以及协生和安慰剂组中转化为CST I的速度.
- 量化了Gardnerella vaginalis和Candida的存在,以评估它们的减少.
主要成果:
- 与安慰剂相比,阴道共生菌显著增加了L.crispatus (p <0.05).
- 与安慰剂组 (11%;p < 0.002) 相比,协生组的参与者中,显著更高的比例实现了转换到CST I (90%).
- 协生治疗导致了Gardnerella vaginalis和Candida水平的降低.
结论:
- 一种多菌株的阴道共生菌有效地促进由L. crispatus (CST I) 主导的阴道微生物组.
- 这种共生菌在恢复有益细菌和减少关键机会性病原体方面表现出显著的有效性.
- 这些发现支持了阴道共生菌作为治疗阴道失生症的治疗策略的潜力.
相关概念视频
Bacterial Flora of the Large Intestine
643
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
643
Drugs for Treatment of Diarrhea-Predominant IBS
294
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
294
Drugs for Treatment of Constipation-Predominant IBS
333
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
333
Surface Membrane Barriers
1.5K
The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
1.5K
Antimicrobial Effectiveness
157
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
157
Sputum Studies II: Culture and Sensitivity
591
Description
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
591


